Addus HomeCare (NASDAQ:ADUS) EVP Cliff Donald Blessing Sells 3,499 Shares of Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Cliff Donald Blessing sold 3,499 shares of the stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $123.91, for a total value of $433,561.09. Following the completion of the transaction, the executive vice president owned 6,684 shares in the company, valued at approximately $828,214.44. The trade was a 34.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Cliff Donald Blessing also recently made the following trade(s):

• On Friday, November 6th, Cliff Donald Blessing sold 2,000 shares of Addus HomeCare stock. The stock was sold at an average price of $124.18, for a total value of $248,360.00.

Addus HomeCare Price Performance

ADUS stock opened at $123.72 on Friday. The business has a 50 day moving average price of $118.30 and a 200 day moving average price of $107.17. The stock has a market cap of $2.30 billion, a price-to-earnings ratio of 20.62, a PEG ratio of 1.65 and a beta of 0.75. Addus HomeCare Corporation has a fifty-two week low of $87.95 and a fifty-two week high of $131.59. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.02.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.79 by $0.04. The firm had revenue of $387.74 million during the quarter, compared to the consensus estimate of $388.72 million. Addus HomeCare had a return on equity of 10.22% and a net margin of 7.39%. The firm’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.56 earnings per share. Equities research analysts anticipate that Addus HomeCare Corporation will post 6.41 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in ADUS. First Trust Advisors LP grew its holdings in shares of Addus HomeCare by 21.9% during the third quarter. First Trust Advisors LP now owns 39,432 shares of the company’s stock worth $4,359,000 after buying an additional 7,084 shares during the last quarter. Private Wealth Asset Management LLC purchased a new stake in Addus HomeCare during the 3rd quarter valued at approximately $187,000. Private Advisor Group LLC raised its stake in Addus HomeCare by 15.5% during the 3rd quarter. Private Advisor Group LLC now owns 2,940 shares of the company’s stock valued at $325,000 after acquiring an additional 394 shares during the last quarter. Boston Partners raised its stake in Addus HomeCare by 18.0% during the 3rd quarter. Boston Partners now owns 290,332 shares of the company’s stock valued at $32,222,000 after acquiring an additional 44,279 shares during the last quarter. Finally, Global Retirement Partners LLC lifted its position in Addus HomeCare by 270.4% during the 3rd quarter. Global Retirement Partners LLC now owns 900 shares of the company’s stock worth $99,000 after acquiring an additional 657 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the stock. UBS Group upped their target price on shares of Addus HomeCare from $145.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, November 5th. Truist Financial lifted their price target on shares of Addus HomeCare from $135.00 to $148.00 and gave the stock a “buy” rating in a research note on Thursday, November 5th. Raymond James Financial set a $137.00 price target on shares of Addus HomeCare in a research report on Monday, September 28th. Citigroup downgraded shares of Addus HomeCare from a “market outperform” rating to a “neutral” rating in a research note on Monday, September 14th. Finally, TD Cowen upped their price objective on shares of Addus HomeCare from $131.00 to $145.00 and gave the company a “buy” rating in a research note on Thursday, November 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $136.33.

Addus HomeCare Company Profile

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.